Why Amphetamines Can Cause Psychosis (Finding #11)

Forced Salience Overload in the Sensitivity Threshold Model

Important Notice

This article discusses a research-based theoretical model that is still under development. It has not been peer reviewed and is shared for educational and informational purposes only. The Sensitivity Threshold Model (STM) is intended to help explain patterns observed in schizophrenia research, not to provide medical advice or treatment guidance. If you or someone you care for is experiencing mental health difficulties, please seek advice from a qualified healthcare professional.

The Empirical Reality

Amphetamine and related psychostimulants can induce hallucinations, delusions, and paranoia that are often clinically indistinguishable from schizophrenia. Risk increases with dose, duration, and sensitization, yet many exposed individuals never progress to psychosis. Repeated exposure lowers the threshold for recurrence, making future episodes more likely even at lower doses.

Any viable model must therefore explain why dopamine-enhancing drugs can replicate the phenomenology of schizophrenia, why only a subset of exposed individuals develop full psychosis, and why vulnerability increases with repeated use.

Why This Finding Matters

Stimulant-induced psychosis is one of the strongest natural experiments in psychiatry. It demonstrates that schizophrenia-like symptoms can be produced acutely—without genetic change or neurodevelopmental disease—yet only in certain individuals and under certain conditions.

A successful theory must integrate pharmacology, individual vulnerability, prediction-error instability, and sensitization into a single mechanistic account.

How the Sensitivity Threshold Model (STM) Explains This

Within the Sensitivity Threshold Model (STM), amphetamine psychosis is interpreted as a pharmacologically forced overload of salience and prediction systems imposed on a vulnerability-dependent neural architecture.

Individuals mentioned in population studies differ in baseline sensitivity of dopaminergic responsivity, sensory gain, inhibitory strength, limbic reactivity, and stress responsiveness. These differences determine how strongly stimulant exposure perturbs network stability.

Amphetamine sharply elevates synaptic dopamine through vesicular release, transporter reversal, and reuptake blockade. This forces excessive precision gain across striatal, limbic, and cortical pathways, overwhelming inhibitory control and thalamocortical filtering. The resulting system-level pattern—salience-network hyper-responsivity, limbic threat amplification, hippocampal contextual instability, and prefrontal regulatory collapse—matches the failure architecture seen in endogenous psychosis. The difference lies in how overload is induced, not what fails.

STM Mechanistic Pathway (Simplified)

Baseline sensitivity architecture→ amphetamine-driven dopaminergic amplification→ salience-network hyper-responsivity→ prediction-error instability→ prefrontal regulatory collapse and limbic threat over-tagging→ threshold crossing→ stimulant-induced psychosis→ sensitization-driven reduction of future thresholds

From Circuits to Experience

At the microcircuit level, amphetamine forces gain on dopaminergic channels that normally regulate signal-to-noise and precision. In vulnerable systems, inhibitory interneurons and thalamocortical relays cannot suppress the resulting noise, causing local computations to destabilize.

At the large-scale circuit level, salience networks become hyper-reactive, amygdala threat appraisal intensifies, hippocampal contextual prediction errors proliferate, and striatal action-selection loops amplify inappropriate significance. Prefrontal regulatory circuits are overwhelmed, leading to failures of working memory, distractor suppression, and top-down control.

From a computational perspective, STM frames these effects as a catastrophic misassignment of precision. Excessive marking of bottom-up signals corrupts prediction-error regulation and generates chaotic belief updating. The system attempts to impose structure on unstable internal and external states, producing referential interpretations, threat narratives, and fully formed delusions.

At the cognitive and behavioral level, this appears as hypervigilance, suspiciousness, racing associative streams, disorganization, hallucinations, and delusional conviction—phenomena indistinguishable from those seen in schizophrenia.

Clinical and Temporal Implications

STM explains why many individuals experience agitation or overstimulation without psychosis: their sensitivity is lower, capacity higher, or background load reduced. In contrast, highly sensitive individuals cross threshold at lower stimulant doses.

Repeated exposure produces sensitization, progressively eroding inhibitory reserve and increasing baseline salience reactivity. This lowers the effective threshold for future episodes, explaining why recurrence becomes more likely over time and why psychosis may eventually occur at doses that were previously tolerated.

Optional Deep Dive: Technical Mechanisms

Forced Precision Gain Amphetamine bypasses normal regulatory controls by artificially elevating dopaminergic gain, pushing precision-weighting far beyond adaptive ranges.

Structural Equivalence to Endogenous Psychosis The resulting network instability mirrors that seen in schizophrenia, supporting a shared failure mechanism rather than a drug-specific syndrome.

Sensitization Effects Repeated dopaminergic overload induces long-term changes in inhibitory stability and salience responsivity, reducing future resilience.

Testable Predictions

STM’s account of amphetamine-induced psychosis yields several falsifiable predictions:

1. Dose–Sensitivity Interaction Individuals with higher baseline sensory gain or dopaminergic responsivity should develop psychosis at lower stimulant doses.

2. Pre-Onset Network Signatures EEG or fMRI markers of salience-network instability should rise sharply immediately prior to symptom emergence.

3. Load Modulation Effects Reducing environmental or psychosocial load should increase the stimulant dose required to induce psychosis.

4. Sensitization Dynamics Repeated stimulant exposure should measurably erode inhibitory network stability and lower future psychosis thresholds.

   
   

STM Integration Summary

Amphetamine-induced psychosis provides a direct, pharmacological demonstration of STM’s core principle: when salience, prediction, and regulatory circuits are driven beyond capacity in a sensitive system, psychosis emerges.

Amphetamines inject artificial load by massively amplifying dopaminergic gain. Sensitivity determines susceptibility; capacity determines resilience and recovery. The resulting threshold crossing reproduces the same system-level failure seen in natural schizophrenia, validating STM’s unified load–capacity–sensitivity architecture.